Triethylene Glycol

Triethylene Glycol

SCHEMBL4603067

C=C.C=C.OCCOCCOCCO

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.85
KMT2A Q03164 4/20 0.85
TSHR P16473 5/20 0.77
MAPK1 P28482 2/20 0.77
ALDH1A1 P00352 4/20 0.50
THRB P10828 1/20 0.50
HTT P42858 1/20 0.50
MAPT P10636 1/20 0.50
APP P05067 5/20 0.34
TP53 P04637 2/20 0.33
HIF1A Q16665 2/20 0.33
HSD17B10 Q99714 1/20 0.33
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
CASP1 P29466 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
SLCO1B3 Q9NPD5 1/20 0.31
SLCO1B1 Q9Y6L6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL421335 1.00 MEN1 (0.85) MEN1KMT2ATSHRMAPK1ALDH1A1
Tetraethylene Glycol SCHEMBL2541664 1.00 MEN1 (0.85) MEN1KMT2ATSHRMAPK1ALDH1A1
Hexaethylene Glycol SCHEMBL9719640 1.00 MEN1 (0.85) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL21384854 1.00 MEN1 (0.85) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL16394863 0.96 MEN1 (0.79) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL6249482 0.96 MEN1 (0.79) MEN1KMT2ATSHRMAPK1ALDH1A1
Triethylene Glycol SCHEMBL444830 0.96 MEN1 (0.79) MEN1KMT2ATSHRMAPK1ALDH1A1
Di(Hydroxyethyl)Ether SCHEMBL8330422 0.96 TSHR (0.83) MEN1KMT2ATSHRMAPK1ALDH1A1
Di(Hydroxyethyl)Ether SCHEMBL8581564 0.96 TSHR (0.83) MEN1KMT2ATSHRMAPK1ALDH1A1
Di(Hydroxyethyl)Ether SCHEMBL486990 0.96

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180202048-A1 PROCESS FOR METALLIZING PLASTIC SURFACES BASF SE (DE) 2018-07-19 US claimed
US-9464164-B2 Method for the preparation of polyesters LANXESS DEUTSCHLAND GMBH (DE) 2016-10-11 US claimed
US-20240200242-A1 KNIT TEXTILES AND UPPERS, AND PROCESSES FOR MAKING THE SAME NIKE, INC. 2024-06-20 US disclosed
US-20240069456-A1 DEVELOPER, DEVELOPER SET, AND IMAGE FORMING APPARATUS KYOCERA DOCUMENT SOLUTIONS INC. (JP) 2024-02-29 US disclosed
US-11811097-B2 Battery tab design, method of manufacture thereof and batteries comprising the same GM Global Technology Operations LLC (US) 2023-11-07 US disclosed
US-11784316-B2 Layered platinum on freestanding palladium nano-substrates for electrocatalytic applications and methods of making thereof GEORGIA TECH RESEARCH CORPORATION (US) 2023-10-10 US disclosed
US-20220226309-A1 MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE BIODELIVERY SCIENCES INTERNATIONAL, INC. (US) 2022-07-21 US disclosed
US-20220140451-A1 BATTERY TAB DESIGN, METHOD OF MANUFACTURE THEREOF AND BATTERIES COMPRISING THE SAME GM Global Technology Operations LLC 2022-05-05 US disclosed
US-20210367243-A1 LAYERED PLATINUM ON FREESTANDING PALLADIUM NANO-SUBSTRATES FOR ELECTROCATALYTIC APPLICATIONS AND METHODS OF MAKING THEREOF GEORGIA TECH RESEARCH CORPORATION 2021-11-25 US disclosed
US-20210332393-A1 MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS GENOMATICA INC (US) 2021-10-28 US disclosed
US-20210069110-A1 NON-AQUEOUS COMPOSITION HAVING DRUG CARRIED THEREIN, AND METHOD FOR PRODUCING SAME TECHNO GUARD CO. LTD. (JP) 2021-03-11 US disclosed
US-20130289201-A1 AQUEOUS PIGMENT DISPERSIONS BASED ON RANDOM POLYURETHANE DISPERSANTS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-10-31 US disclosed
US-20130210992-A1 METHOD OF PREPARING PIGMENT DISPERSIONS E I DU PONT DE NEMOURS AND COMPANY (US) 2013-08-15 US disclosed
US-20130203904-A1 STERICALLY HINDERED POLYMERIC AMINES AND THEIR USE AS POLYMER STABILIZERS 3V SIGMA S.P.A. (IT) 2013-08-08 US disclosed
US-20130186303-A1 Bioplastics BUDINA ERICA (US) 2013-07-25 US disclosed
EP-1673222-B1 PROCESS FOR PRODUCTION OF HEAT-SENSITIVE IMAGEABLE ELEMENTS KODAK GRAPHIC COMM GMBH (DE) 2008-07-09 EP disclosed
US-20070292809-A1 Process for the Production of Double-Layer Heat-Sensitive Imageable Elements KODAK POLYCHROME GRAPHICS, GMBH (DE) 2007-12-20 US disclosed
EP-1673222-A1 PROCESS FOR PRODUCTION OF HEAT-SENSITIVE IMAGEABLE ELEMENTS Kodak Polychrome Graphics GmbH (DE) 2006-06-28 EP disclosed
WO-2005039878-A1 PROCESS FOR PRODUCTION OF HEAT-SENSITIVE IMAGEABLE ELEMENTS KODAK POLYCHROME GRAPHICS GMBH (DE) 2005-05-06 WO disclosed
US-4185059-A NONSOLVENT, GAS FORMING COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1980-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203904-A1 STERICALLY HINDERED POLYMERIC AMINES AND THEIR USE AS POLYMER STABILIZERS C1S, AAAS, CBR3 MEN1 4442/4885KMT2A 3443/4885TSHR 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.